Ifex Related Clinical Trials
Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors [Completed]
Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus [Active, not recruiting]
Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors [Completed]
Bortezomib, Ifosfamide, and Vinorelbine in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy [Suspended]
Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin [Recruiting]
Assess the Safety, Efficacy, and Pharmacokinetics of Eltrombopag Given to Subjects Receiving Adriamycin and Ifosfamide [Recruiting]
Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors [Recruiting]
A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma [Completed]
Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma [Active, not recruiting]
TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients [Recruiting]
Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma [Recruiting]
A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant [Recruiting]
Phase II Study of Doxorubicin, Ifosfamide, and Bevacizumab in Sarcoma. [Recruiting]
Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma [Recruiting]
Ifosfamide in Treating Patients With Meningeal Tumors [Withdrawn]
Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors [Completed]
Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [Active, not recruiting]
Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Metastatic Testicular Cancer [Active, not recruiting]
Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma [Active, not recruiting]
Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma [Recruiting]
Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children [Completed]
Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma [Active, not recruiting]
Docetaxel and Ifosfamide in Treating Women With Metastatic Breast Cancer [Recruiting]
Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors [Recruiting]
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors [Recruiting]
Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma [Recruiting]
Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma [Recruiting]
A Phase II Trial of Adjuvant Radiation Therapy With Ifosfamide and Cisplatin in Patients With MMT of the Uterus [Recruiting]
Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors [Recruiting]
Randomised Study Comparing Three Chemotherapy Regimens in Non-Small Cell Lung Cancer [Recruiting]
Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma [Completed]
Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma [Active, not recruiting]
Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS) [Completed]
Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC [Completed]
A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL [Recruiting]
Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma [Recruiting]
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma [Active, not recruiting]
High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma [Active, not recruiting]
Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Primary Refractory Lymphoma [Recruiting]
Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma [Active, not recruiting]
Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma [Active, not recruiting]
Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium [Completed]
Combination Chemotherapy in Treating Patients With Metastatic Kidney Cancer [Active, not recruiting]
Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer [Active, not recruiting]
Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma [Active, not recruiting]
Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy [Completed]
Chemotherapy in Treating Patients With Advanced Sarcoma [Active, not recruiting]
Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma [Completed]
Combination Chemotherapy in Treating Patients With Germ Cell Tumors That Have Not Responded to Previous Cisplatin [Active, not recruiting]
A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer [Active, not recruiting]
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer [Active, not recruiting]
Dose Augmented Rituximab and Ice for Patients With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell Non-Hodgkin's Lymphoma [Recruiting]
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors [Recruiting]
Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors [Recruiting]
Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia [Completed]
Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma [Recruiting]
Efficacy Study of Outpatient Therapy for Lymphoma [Completed]
Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide [Suspended]
AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin [Recruiting]
CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide [Recruiting]
Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall [Active, not recruiting]
Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer [Completed]
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma [Active, not recruiting]
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma [No longer recruiting]
Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma [Active, not recruiting]
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer [Active, not recruiting]
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer [Active, not recruiting]
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer
Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed During Surgery [No longer recruiting]
High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer [Active, not recruiting]
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma [Completed]
Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer [Active, not recruiting]
A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma [Recruiting]
Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma [Active, not recruiting]
Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer [Active, not recruiting]
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors [Active, not recruiting]
Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma [Completed]
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer [Active, not recruiting]
Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood [Terminated]
Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI) [Recruiting]
Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma [Completed]
Dose Evaluation Study Of Oral Eltrombopag In Patients With Sarcoma Receiving The Adriamycin And Ifosfamide Regimen [Recruiting]
Rituximab and Combination Chemotherapy Followed By Thalidomide in Treating Patients With Previously Untreated Mantle Cell Lymphoma [Recruiting]
Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Recruiting]
Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL [Recruiting]
A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma [Recruiting]
Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy [Recruiting]
Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis [Recruiting]
Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma [Recruiting]
Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer [Active, not recruiting]
Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain [No longer recruiting]
Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma [No longer recruiting]
Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma [Recruiting]
A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors [Completed]
Large Cell Lymphoma Pilot Study III [Completed]
Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma [Recruiting]
PET Scan Combined With CT Scan in Predicting Response in Patients Undergoing Chemotherapy and Surgery for Soft Tissue Sarcoma [Recruiting]
|
